The Pleural Effusion And Symptom Evaluation (PLEASE) study of breathlessness in patients with a symptomatic pleural effusion

Introduction Pathophysiology changes associated with pleural effusion, its drainage and factors governing symptom response are poorly understood. Our objective was to determine: 1) the effect of pleural effusion (and its drainage) on cardiorespiratory, functional and diaphragmatic parameters; and 2) the proportion as well as characteristics of patients with breathlessness relief post-drainage. Methods Prospectively enrolled patients with symptomatic pleural effusions were assessed at both pre-therapeutic drainage and at 24–36 h post-therapeutic drainage. Results 145 participants completed pre-drainage and post-drainage tests; 93% had effusions ≥25% of hemithorax. The median volume drained was 1.68 L. Breathlessness scores improved post-drainage (mean visual analogue scale (VAS) score by 28.0±24 mm; dyspnoea-12 (D12) score by 10.5±8.8; resting Borg score before 6-min walk test (6-MWT) by 0.6±1.7; all p<0.0001). The 6-min walk distance (6-MWD) increased by 29.7±73.5 m, p<0.0001. Improvements in vital signs and spirometry were modest (forced expiratory volume in 1 s (FEV1) by 0.22 L, 95% CI 0.18–0.27; forced vital capacity (FVC) by 0.30 L, 95% CI 0.24–0.37). The ipsilateral hemi-diaphragm was flattened/everted in 50% of participants pre-drainage and 48% of participants exhibited paradoxical or no diaphragmatic movement. Post-drainage, hemi-diaphragm shape and movement were normal in 94% and 73% of participants, respectively. Drainage provided meaningful breathlessness relief (VAS score improved ≥14 mm) in 73% of participants irrespective of whether the lung expanded (mean difference 0.14, 95% CI 10.02–0.29; p=0.13). Multivariate analyses found that breathlessness relief was associated with significant breathlessness pre-drainage (odds ratio (OR) 5.83 per standard deviation (sd) decrease), baseline abnormal/paralyzed/paradoxical diaphragm movement (OR 4.37), benign aetiology (OR 3.39), higher pleural pH (OR per sd increase 1.92) and higher serum albumin level (OR per sd increase 1.73). Conclusions Breathlessness and exercise tolerance improved in most patients with only a small mean improvement in spirometry and no change in oxygenation. Breathlessness improvement was similar in participants with and without trapped lung. Abnormal hemi-diaphragm shape and movement were independently associated with relief of breathlessness post-drainage. The majority of patients improve after pleural fluid drainage. Abnormal diaphragmatic function may be an important contributor to breathlessness in patients with pleural effusion. http://bit.ly/2SyF8RW

[1]  P. Zimmerman,et al.  In patients with unilateral pleural effusion, restricted lung inflation is the principal predictor of increased dyspnoea , 2018, PloS one.

[2]  D. Feller-Kopman,et al.  Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial. , 2018, The Lancet. Respiratory medicine.

[3]  Y. C. Lee,et al.  Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial , 2017, JAMA.

[4]  N. Rahman,et al.  Assessment of patient-reported outcome measures in pleural interventions , 2017, BMJ Open Respiratory Research.

[5]  Y. C. Lee,et al.  Protocol of the PLeural Effusion And Symptom Evaluation (PLEASE) study on the pathophysiology of breathlessness in patients with symptomatic pleural effusions , 2016, BMJ Open.

[6]  D. McKenzie,et al.  Physical activity levels improve following discharge in people admitted to hospital with an acute exacerbation of chronic obstructive pulmonary disease , 2016, Chronic respiratory disease.

[7]  P. Eastwood,et al.  Physiology of breathlessness associated with pleural effusions , 2015, Current opinion in pulmonary medicine.

[8]  J. Stradling,et al.  Defining the Minimal Important Difference for the Visual Analogue Scale Assessing Dyspnea in Patients with Malignant Pleural Effusions , 2015, PloS one.

[9]  J. Yorke,et al.  The assessment of breathlessness in pulmonary arterial hypertension: Reliability and validity of the Dyspnoea-12 , 2014, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[10]  Thierry Troosters,et al.  An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease , 2014, European Respiratory Journal.

[11]  L. Brochard,et al.  Effects of pleural effusion drainage on oxygenation, respiratory mechanics, and hemodynamics in mechanically ventilated patients. , 2014, Annals of the American Thoracic Society.

[12]  R. Davies,et al.  Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. , 2012, JAMA.

[13]  C. Shuldham,et al.  Assessment of Dyspnea in Asthma: Validation of the Dyspnea-12 , 2011, The Journal of asthma : official journal of the Association for the Care of Asthma.

[14]  J. M. Salge,et al.  Improvements in the 6-min walk test and spirometry following thoracentesis for symptomatic pleural effusions. , 2011, Chest.

[15]  N. Adhikari,et al.  Utility and safety of draining pleural effusions in mechanically ventilated patients: a systematic review and meta-analysis , 2011, Critical care.

[16]  Edmund Neville,et al.  Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010 , 2010, Thorax.

[17]  A. Holland,et al.  Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. , 2010, Archives of physical medicine and rehabilitation.

[18]  P. Jones,et al.  Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12 , 2009, Thorax.

[19]  Jeng-shing Wang,et al.  Improved lung function after thoracocentesis in patients with paradoxical movement of a hemidiaphragm secondary to a large pleural effusion , 2007, Respirology.

[20]  P. Mayo,et al.  Effect of thoracentesis on respiratory mechanics and gas exchange in the patient receiving mechanical ventilation. , 2006, Chest.

[21]  R. Kaplan,et al.  Minimal clinically important difference for the UCSD Shortness of Breath Questionnaire. , 2005, Journal of cardiopulmonary rehabilitation.

[22]  J. Hankinson,et al.  General considerations for lung function testing , 2005, European Respiratory Journal.

[23]  A. Ries,et al.  Minimally Clinically Important Difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale , 2005, COPD.

[24]  R. Light,et al.  Large Pleural Effusions Occurring after Coronary Artery Bypass Grafting , 1999, Annals of Internal Medicine.

[25]  L. Hydo,et al.  Beneficial effects of chest tube drainage of pleural effusion in acute respiratory failure refractory to positive end-expiratory pressure ventilation. , 1998, Surgery.

[26]  J. Roca,et al.  Ventilation-perfusion mismatch in patients with pleural effusion: effects of thoracentesis. , 1997, American journal of respiratory and critical care medicine.

[27]  Jeng-shing Wang,et al.  Changes in pulmonary mechanics and gas exchange after thoracentesis on patients with inversion of a hemidiaphragm secondary to large pleural effusion. , 1995, Chest.

[28]  S. T. Elliott,et al.  Pleural effusions, diaphragm inversion, and paradox: new observations using sonography. , 1995, AJR. American journal of roentgenology.

[29]  G. Gamsu,et al.  Effect of varying kVp on visibility of epicardial fat stripe in pericardial effusions. , 1995, AJR. American journal of roentgenology.

[30]  R. Light,et al.  The incidence of pleural effusion in a well-defined region. Epidemiologic study in central Bohemia. , 1993, Chest.

[31]  R. B. Himelman,et al.  The prognostic value of loculations in parapneumonic pleural effusions. , 1986, Chest.

[32]  D. Nauffal,et al.  Effect of thoracentesis on pulmonary gas exchange. , 1983, Thorax.

[33]  M. Estenne,et al.  Mechanism of relief of dyspnea after thoracocentesis in patients with large pleural effusions. , 1983, The American journal of medicine.

[34]  R. Brandstetter,et al.  Hypoxemia after thoracentesis. A predictable and treatable condition. , 1979, JAMA.

[35]  N. Zamel,et al.  Changes in pulmonary mechanics and gas exchange following thoracocentesis. , 1978, Chest.

[36]  R. Mulvey THE EFFECT OF PLEURAL FLUID ON THE DIAPHRAGM. , 1965, Radiology.

[37]  N. Zamcheck,et al.  THE EFFECTS OF PLEURAL EFFUSION ON RESPIRATION AND CIRCULATION IN MAN. , 1944, The Journal of clinical investigation.

[38]  Richard W. Bohannon,et al.  Minimal clinically important difference for change in 6-minute walk test distance of adults with pathology: a systematic review , 2016 .

[39]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[40]  M. Raza Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010 , 2011 .

[41]  A. Russell,et al.  Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease. , 2011, Chest.

[42]  G. Borg Psychophysical bases of perceived exertion. , 1982, Medicine and science in sports and exercise.

[43]  D. Long Hypoxemia after thoracentesis. , 1980, Current surgery.

[44]  J. Fourre,et al.  Effect of thoracentesis on arterial oxygen tension. , 1978, Respiration; international review of thoracic diseases.